/

Empresas

Me

No verificado

Merck

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

38 Comunicados de prensa

Ver todos los comunicados de prensa

08/06/2026

Anuncios breves

Merck Appoints New Heads of Discovery Solutions and Strategy & Business Development for Life Science Business Sector

Fuente

Editor

1.00

0

21/05/2026

Oncología

Salud

Medicina - Varios

Ciencia

Farmacéutica

Industria

Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer

Fuente

Editor

1.00

0

07/05/2026

Anuncios breves

Merck Becomes Sole Testing Provider for Genetix Biotherapeutics’ FDA-Approved Gene Therapies

Fuente

Editor

1.00

0

30/04/2026

Merck Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin Manifestations

Fuente

Editor

1.00

0

21/04/2026

Anuncios breves

Merck Launches First Bio-Based Solvent Portfolio for High-Performance Liquid Chromatography

Fuente

Editor

1.00

0

01/04/2026

Anuncios breves

Merck Completes Acquisition of JSR Life Sciences’ Chromatography Business, Expanding Protein A Capabilities and Downstream Portfolio

Fuente

Editor

1.00

0

18/03/2026

Anuncios breves

Merck Marks 10 Years of SPARK™ Mobilizing Employee Volunteers to Help Inspire the Next Generation in STEM

Fuente

Editor

1.00

0

12/01/2026

Eventos

Industria

Salud

Farmacéutica

Medicina - Varios

Oncología

FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor

Fuente

Editor

1.00

0

12/01/2026

Eventos

Industria

Salud

Farmacéutica

Medicina - Varios

Oncología

FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor

Fuente

Editor

1.00

0

22/12/2025

Oncología

Automóvil/Automoción

Salud

Sanidad

Farmacéutica

Industria

Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0